GGrantIndex
← Search

ACTG301--TRIAL OF MEMANTINE FOR AIDS DEMENTIA COMPLEX W/ANTIRETROVIRAL THERAPY

$564M01FY2000RRNIH

University Of California San Francisco, San Francisco CA

Investigators

Linked publications & trials

Abstract

In this study investigators will assess the possible efficacy of oral memantine, a NMDA antagonist, in ameliorating AIDS dementia complex. Using a randomized double-blind placebo-controlled design, this study will use neuropsychiatric exams, neurologic exams, and lumbar puncture test results to determine possible efficacy endpoints.

View original record on NIH RePORTER →